1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 51 F.Supp.2d
  5. 51 F.Supp.2d 302 (1999)
 

YAMANOUCHI PHARMA. CO. v. DANBURY PHARMA., INC.

Nos. 97 CIV. 3403 RO, 97 CIV. 8357 RO.

51 F.Supp.2d 302 (1999)

YAMANOUCHI PHARMACEUTICAL CO., LTD., and Merck & Co., Inc., Plaintiffs, v. DANBURY PHARMACAL, INC., and Schein Pharmaceutical, Inc., Defendants. Yamanouchi Pharmaceutical Co., Ltd., And Merck & Co., Inc., Plaintiffs, v. Marsam Pharmaceuticals, Inc., and Schein Pharmaceutical, Inc. Defendants.

United States District Court, S.D. New York.

June 1, 1999.

Attorney(s) appearing for the Case

Fitzpatrick, Cella, Harper & Scinto, New York City, Robert L. Baechtold, Hugh C. Barrett, Brian V. Slater, for Plaintiff Yamanouchi Pharmaceutical Co.

William Krovatin, Rahway, NJ, Arnold White & Durkee, Houston, TX, John F. Lynch, for Plaintiff Merck & Co., Inc.

Cummings & Lockwood, Stamford, CT, Barry Kramer, Steven J. Moore, James Jakobsen, for Defendants.

MEMORANDUM AND ORDER

OWEN, District Judge.

I presided over the trial here that lasted four days in April 1998. I found that the defendants willfully infringed the plaintiffs' patent for famotidine in violation of the Hatch-Waxman Act, Yamanouchi Pharmaceutical Co. v. Danbury Pharmacal, Inc., 21 F.Supp.2d 366, 378 (S.D.N.Y.1998), familiarity with which is assumed. I found that this case constituted an...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases